Purchase Order HHSN272201800363P
Award Date 1/30/18
Potential Completion Date 1/30/19
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA 20164, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,920.00 firm fixed-price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract was awarded on September 24, 2018, with a completion date of October 24, 2018, and the place of performance is Bethesda, Maryland. This contract does not have a set-aside designation.
- <p>The federal contract award HHSN272201601160P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to ABI Scientific Inc. for the product KIFUNENSINE. The $11,280.00 firm fixed price purchase order has an ultimate completion date of August 26, 2016. This contract was set aside for a small business, and ABI Scientific Inc. is a minority-owned, for-profit Asian-Pacific American organization.</p>
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $33,000 firm fixed price purchase order to ABI Scientific Inc. to provide cell growth enhancers and mediums. Under the contract, ABI Scientific will deliver ProBooster, CelBooster, and AbBooster products totaling 90 units to support NIAID's structural analysis, immunogen screening, and pre-clinical animal studies for vaccine development targeting HIV-1, SARS-CoV-2, and other viruses. The...
- The Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to United Biosystems Inc., a minority-owned and Asian-Pacific American-owned for-profit manufacturer, to provide 500 units of the product "TM5501-4 TRUEFECT-MAX, FOR ADHERENT OR SUSPENSION CELLS" at a unit price of $196.00, for a total ceiling value of $98,099.00. The contract does not have a set-aside designation and was...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Abpro Corporation, a minority-owned and Asian-Pacific American-owned for-profit organization, for subcloning and isotyping services. The contract has a ceiling value of $3,250.00 and was awarded on May 1, 2013, with a final completion date of September 24, 2013. The contract is not set-aside and there is no information provided about any subcontractors....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The $4,140 contract is for infectious disease research functions and does not have a set-aside designation. AAHI, which also operates under the names Aahi, Idri, and Infectious Disease Research Institute, conducts research and...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...
- <p>This federal contract award, valued at $13,390.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract was awarded to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business, for the provision of proteins and antibodies. The contract is a firm fixed price purchase order with an ultimate completion date of August 5, 2016. There is no set-aside designation for this award.</p>